View in EDS PDF Full Text

Long-term outcomes of induction chemotherapy followed by chemoradiotherapy vs chemoradiotherapy alone as treatment of unresectable head and neck cancer: follow-up of the Spanish Head and Neck Cancer Group (TTCC) 2503 Trial.

Saved in:
Bibliographic Details
Title: Long-term outcomes of induction chemotherapy followed by chemoradiotherapy vs chemoradiotherapy alone as treatment of unresectable head and neck cancer: follow-up of the Spanish Head and Neck Cancer Group (TTCC) 2503 Trial.
Authors: Hitt R; Medical Oncology Department, Hospital Universitario Severo Ochoa, Avda. de Orellana, s/n, 28911, Leganés (Madrid), Spain. rhitt@telefonica.net., Iglesias L; Medical Oncology Department, Hospital Universitario, 12 de Octubre, Madrid, Spain., López-Pousa A; Medical Oncology Department, Hospital de la Santa Creu i Sant Pau, Calalunya, Spain., Berrocal-Jaime A; Medical Oncology Department, Consorci Hospital General Universitari de Valencia, Valencia, Spain., Grau JJ; Medical Oncology Department, Hospital Clinic de Barcelona, Catalunya, Spain., García-Girón C; Medical Oncology Department, Hospital Universitario de Burgos, Castilla y León, Spain., Martínez-Trufero J; Medical Oncology Department, Hospital Universitario Miguel Servet, Aragón, Spain., Guix M; Medical Oncology Department, Hospital del Mar, Barcelona, Spain.; Cancer Research Program (CIBERONC), Institut Mar d Investigacions Mèdiques (IMM), Barcelona, Spain., Lambea-Sorrosal J; Medical Oncology Department, Hospital Clínico Lozano Blesa, Zaragoza, Spain., Del Barco-Morillo E; Medical Oncology Department, Hospital Universitario de Salamanca, Castilla y León, Spain.; Institute for Biomedical Research of Salamanca (IBSAL), Castilla y León, Spain., León-Vintró X; ENT Department, Hospital de la Santa Creu i Sant Pau, Catalunya, Spain., Cunquero-Tomas AJ; Medical Oncology Department, Consorci Hospital General Universitari de Valencia, Valencia, Spain., Baste N; Medical Oncology Department, Hospital Clinic de Barcelona, Catalunya, Spain., Ocaña A; Medical Oncology Department, Hospital Universitario de Salamanca, Castilla y León, Spain.; Institute for Biomedical Research of Salamanca (IBSAL), Castilla y León, Spain., Cruz-Hernández JJ; Medical Oncology Department, Hospital Universitario de Salamanca, Castilla y León, Spain.; Institute for Biomedical Research of Salamanca (IBSAL), Castilla y León, Spain.
Corporate Authors: the Spanish Head and Neck Cancer Cooperative Group (TTCC)
Source: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico [Clin Transl Oncol] 2021 Apr; Vol. 23 (4), pp. 764-772. Date of Electronic Publication: 2020 Aug 14.
Publication Type: Journal Article; Observational Study
Journal Info: Publisher: Springer Italia Country of Publication: Italy NLM ID: 101247119 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1699-3055 (Electronic) Linking ISSN: 1699048X NLM ISO Abbreviation: Clin Transl Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 32797376
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Long-term outcomes of induction chemotherapy followed by chemoradiotherapy vs chemoradiotherapy alone as treatment of unresectable head and neck cancer: follow-up of the Spanish Head and Neck Cancer Group (TTCC) 2503 Trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Hitt+R%22">Hitt R</searchLink>; Medical Oncology Department, Hospital Universitario Severo Ochoa, Avda. de Orellana, s/n, 28911, Leganés (Madrid), Spain. rhitt@telefonica.net.<br /><searchLink fieldCode="AU" term="%22Iglesias+L%22">Iglesias L</searchLink>; Medical Oncology Department, Hospital Universitario, 12 de Octubre, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22López-Pousa+A%22">López-Pousa A</searchLink>; Medical Oncology Department, Hospital de la Santa Creu i Sant Pau, Calalunya, Spain.<br /><searchLink fieldCode="AU" term="%22Berrocal-Jaime+A%22">Berrocal-Jaime A</searchLink>; Medical Oncology Department, Consorci Hospital General Universitari de Valencia, Valencia, Spain.<br /><searchLink fieldCode="AU" term="%22Grau+JJ%22">Grau JJ</searchLink>; Medical Oncology Department, Hospital Clinic de Barcelona, Catalunya, Spain.<br /><searchLink fieldCode="AU" term="%22García-Girón+C%22">García-Girón C</searchLink>; Medical Oncology Department, Hospital Universitario de Burgos, Castilla y León, Spain.<br /><searchLink fieldCode="AU" term="%22Martínez-Trufero+J%22">Martínez-Trufero J</searchLink>; Medical Oncology Department, Hospital Universitario Miguel Servet, Aragón, Spain.<br /><searchLink fieldCode="AU" term="%22Guix+M%22">Guix M</searchLink>; Medical Oncology Department, Hospital del Mar, Barcelona, Spain.; Cancer Research Program (CIBERONC), Institut Mar d Investigacions Mèdiques (IMM), Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Lambea-Sorrosal+J%22">Lambea-Sorrosal J</searchLink>; Medical Oncology Department, Hospital Clínico Lozano Blesa, Zaragoza, Spain.<br /><searchLink fieldCode="AU" term="%22Del+Barco-Morillo+E%22">Del Barco-Morillo E</searchLink>; Medical Oncology Department, Hospital Universitario de Salamanca, Castilla y León, Spain.; Institute for Biomedical Research of Salamanca (IBSAL), Castilla y León, Spain.<br /><searchLink fieldCode="AU" term="%22León-Vintró+X%22">León-Vintró X</searchLink>; ENT Department, Hospital de la Santa Creu i Sant Pau, Catalunya, Spain.<br /><searchLink fieldCode="AU" term="%22Cunquero-Tomas+AJ%22">Cunquero-Tomas AJ</searchLink>; Medical Oncology Department, Consorci Hospital General Universitari de Valencia, Valencia, Spain.<br /><searchLink fieldCode="AU" term="%22Baste+N%22">Baste N</searchLink>; Medical Oncology Department, Hospital Clinic de Barcelona, Catalunya, Spain.<br /><searchLink fieldCode="AU" term="%22Ocaña+A%22">Ocaña A</searchLink>; Medical Oncology Department, Hospital Universitario de Salamanca, Castilla y León, Spain.; Institute for Biomedical Research of Salamanca (IBSAL), Castilla y León, Spain.<br /><searchLink fieldCode="AU" term="%22Cruz-Hernández+JJ%22">Cruz-Hernández JJ</searchLink>; Medical Oncology Department, Hospital Universitario de Salamanca, Castilla y León, Spain.; Institute for Biomedical Research of Salamanca (IBSAL), Castilla y León, Spain.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22the+Spanish+Head+and+Neck+Cancer+Cooperative+Group+%28TTCC%29%22">the Spanish Head and Neck Cancer Cooperative Group (TTCC)</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101247119%22">Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico</searchLink> [Clin Transl Oncol] 2021 Apr; Vol. 23 (4), pp. 764-772. <i>Date of Electronic Publication: </i>2020 Aug 14.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Observational Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Italia%22">Springer Italia </searchLink><i>Country of Publication: </i>Italy <i>NLM ID: </i>101247119 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1699-3055 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%221699048X%22">1699048X </searchLink><i>NLM ISO Abbreviation: </i>Clin Transl Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=32797376
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s12094-020-02467-8
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 764
    Titles:
      – TitleFull: Long-term outcomes of induction chemotherapy followed by chemoradiotherapy vs chemoradiotherapy alone as treatment of unresectable head and neck cancer: follow-up of the Spanish Head and Neck Cancer Group (TTCC) 2503 Trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Hitt R
      – PersonEntity:
          Name:
            NameFull: Iglesias L
      – PersonEntity:
          Name:
            NameFull: López-Pousa A
      – PersonEntity:
          Name:
            NameFull: Berrocal-Jaime A
      – PersonEntity:
          Name:
            NameFull: Grau JJ
      – PersonEntity:
          Name:
            NameFull: García-Girón C
      – PersonEntity:
          Name:
            NameFull: Martínez-Trufero J
      – PersonEntity:
          Name:
            NameFull: Guix M
      – PersonEntity:
          Name:
            NameFull: Lambea-Sorrosal J
      – PersonEntity:
          Name:
            NameFull: Del Barco-Morillo E
      – PersonEntity:
          Name:
            NameFull: León-Vintró X
      – PersonEntity:
          Name:
            NameFull: Cunquero-Tomas AJ
      – PersonEntity:
          Name:
            NameFull: Baste N
      – PersonEntity:
          Name:
            NameFull: Ocaña A
      – PersonEntity:
          Name:
            NameFull: Cruz-Hernández JJ
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 04
              Text: 2021 Apr
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-electronic
              Value: 1699-3055
          Numbering:
            – Type: volume
              Value: 23
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
              Type: main
ResultId 1